Valuation: Remus Pharmaceuticals Limited

Market Cap 7.32B 76.5M 65.5M 61.11M 56.08M 105M 107M 725M 283M 3.67B 287M 281M 12.15B P/E 2024
45.4x
P/E 2025 45.4x
Enterprise Value 7.28B 76.05M 65.12M 60.76M 55.75M 105M 107M 721M 281M 3.65B 286M 279M 12.07B EV / Sales 2024
4.69x
EV / Sales 2025 2.12x
Free-Float
24.75%
Yield 2024
0.09%
Yield 2025 0.07%
1 day+8.06%
1 week+12.38%
Current month+31.92%
1 month+29.38%
3 months+7.74%
6 months+34.64%
Current year+35.26%
1 week 856
Extreme 856
967.05
1 month 705
Extreme 705
967.05
Current year 580
Extreme 580
967.05
1 year 580
Extreme 580
967.05
3 years 506.25
Extreme 506.25
1,417.38
5 years 213.91
Extreme 213.90625
1,417.38
10 years 213.91
Extreme 213.90625
1,417.38
Manager TitleAgeSince
Chief Executive Officer 38 2023-01-15
Director of Finance/CFO - 2026-07-08
Compliance Officer - 2023-01-05
Director TitleAgeSince
Director/Board Member 38 2015-09-20
Chairman 41 2015-09-20
Director/Board Member 38 2015-09-20
Change 5-day change 1-year change 3-year change Capi.($)
+8.06%+12.38%+3.31%+64.78% 107M
-2.81%+2.93%+76.40%+126.23% 1,141B
-2.21%+2.02%+49.50%+59.77% 659B
-1.56%+4.39%+25.19%+74.37% 470B
+1.20%+1.72%+42.89%+45.78% 366B
-0.61%+1.72%+25.21%+41.34% 302B
+0.32%+3.30%+2.60%+13.42% 254B
-1.95%+3.80%+46.31%+66.37% 239B
-1.10%-1.12%-14.91%-52.66% 207B
-2.82%+3.84%+20.81%+88.89% 183B
Average -0.24%+4.09%+27.73%+52.83% 382.11B
Weighted average by Cap. -1.34%+4.31%+43.81%+71.26%

Financials

2024 2025
Net sales 2.13B 22.25M 19.05M 17.77M 16.31M 30.64M 31.24M 211M 82.18M 1.07B 83.53M 81.71M 3.53B 6.2B 64.83M 55.51M 51.79M 47.52M 89.3M 91.06M 614M 240M 3.11B 243M 238M 10.29B
Net income 215M 2.25M 1.93M 1.8M 1.65M 3.1M 3.16M 21.33M 8.32M 108M 8.45M 8.27M 357M 291M 3.04M 2.6M 2.43M 2.23M 4.18M 4.27M 28.79M 11.22M 146M 11.41M 11.16M 482M
Net Debt -178M -1.86M -1.59M -1.49M -1.36M -2.56M -2.61M -17.63M -6.87M -89.2M -6.98M -6.83M -295M -42.9M -448K -384K -358K -329K -618K -630K -4.25M -1.66M -21.5M -1.68M -1.65M -71.18M
Logo Remus Pharmaceuticals Limited
Remus Pharmaceuticals Limited is an India-based company, which is engaged in marketing and distribution of finished formulations of pharmaceutical drugs. The Company also deals in active pharmaceutical ingredients (APIs). It also provides technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries. It offers a range of pharmaceutical formulations and products manufactured on contract manufacturing and on a loan license basis. It deals in drug forms like capsules, cream, eye drops, gel, infusion, inhalation, inhaler, injection, nail lacquer, nasal solution, nasal spray, nebulizer, ointment, ophthalmic, oral gel, oral solution, oral suspension, sachet, suspension and tablet. The Company offers its products in various therapeutic categories, such as oncology, cardiovascular, anti-diabetic, central nervous system (CNS), immunosuppressants, anti-biotic - antibacterial and dermatology.
Employees
-
Date Price Change Volume
26-08-20 949.80 +8.06% 47,400
26-08-19 ₹878.95 -1.66% 4,100
26-08-18 ₹893.80 -1.49% 2,800
26-08-17 ₹907.30 +1.11% 21,700
26-08-14 ₹897.35 +2.09% 30,900
  1. Stock Market
  2. Stocks
  3. REMUS Stock